申请人:THE REGENTS OF THE UNIVERSITY OF MICHIGAN
公开号:US20210353610A1
公开(公告)日:2021-11-18
The present disclosure provides compounds represented by Formula I: and the pharmaceutically acceptable salts and solvates thereof, wherein R
1a
, R
1b
, R
1c
, E, G, and Q are as defined as set forth in the specification. The present disclosure also provides compounds of Formula I for use to treat cancer or any other disease, condition, or disorder that is responsive to inhibition of menin.